A Connecticut federal judge has sided with the US Department of Health and Human Services (HHS) in Boehringer Ingelheim’s challenge to Medicare’s drug price negotiation programme, rejecting the company’s position.Judge Michael Shea denied all of Boehringer’s claims that the Medicare negotiation programme the key policy in President Biden’s flagship Inflation Reduction Act, is unconstitutional.
